Bryan G. Helwig is an associate with McDonnell Boehnen Hulbert & Berghoff LLP (MBHB). He concentrates his practice on intellectual property law matters, including patent prosecution, as well as providing infringement and patentability analyses in the biotechnology, pharmaceuticals and medical device and diagnostic areas. Prior to joining MBHB, Helwig was a principal investigator for the U.S. Department of Defense wherein he directed a research portfolio tasked with developing pharmaceutical and non-pharmaceutical therapies as well as the advancement of molecular device technologies that aid combat survival in extreme environments.